Claris Lifesciences lost 0.27% to Rs 223 at 10:11 IST on BSE as the stock turned ex-dividend today, 4 April 2013, for dividend of Rs 2 per share for the year ended 31 December 2012.
Meanwhile, the S&P BSE Sensex was down 154.77 points or 0.82% at 18,646.87.
On BSE, 1,925 shares were traded in the counter as against average daily volume of 64,399 shares in the past one quarter.
The stock hit a high of Rs 224 and a low of Rs 219.30 so far during the day. The stock had hit a 52-week low of Rs 140 on 4 April 2012. The stock had hit a record high of Rs 292.20 on 5 December 2012.
The stock had outperformed the market over the past one month till 3 April 2013, surging 15.56% compared with the Sensex's 0.62% fall. The scrip had also outperformed the market in past one quarter, rising 1.11% as against Sensex's 4.87% fall.
The small-cap company has equity capital of Rs 63.82 crore. Face value per share is Rs 10.
More From This Section
Before turning ex-dividend, the stock offered a dividend yield of 0.89% based on the closing price of Rs 223.60 on Wednesday, 3 April 2013.
Claris Lifesciences' consolidated net profit declined 27.3% to Rs 25.19 crore on 3.9% growth in net sales to Rs 193.59 crore in Q4 December 2012 over Q4 December 2011.
Claris Lifesciences is a sterile injectables pharmaceutical company with a market presence in 96 countries worldwide. It primarily manufactures and markets products across multiple markets, and therapeutic segments. A significant majority of these products are generic drugs that are capable of being directly injected into the human body and are predominantly used in the treatment of critical illnesses. Its customer base primarily includes government and private hospitals, aid agencies, and nursing homes.
Powered by Capital Market - Live News